Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Holcim Aktie 1221405 / CH0012214059

19.06.2026 07:00:03

Holcim completes acquisition of Xella

Holcim Group Services Ltd / Key word(s): Acquisition
Holcim completes acquisition of Xella

19.06.2026 / 07:00 CET/CEST


  • A European leader in the highly attractive walling market with projected 2026 net sales of EUR 1 billion
  • Complementary building solutions offering to Holcim, powered by leading premium brands Ytong, Hebel, Silka and Multipor
  • Strategic value-accretive acquisition to deliver run-rate EBITDA synergies of EUR 60 million in year three, EPS accretive in year one
  • Acquisition advances Holcim’s NextGen Growth 2030 strategy, accelerating its vision to be the leading partner for sustainable construction
     

Holcim has completed the acquisition of Xella, a leader in the highly attractive European walling market with projected 2026 net sales of EUR 1 billion. The acquisition expands Holcim’s building solutions portfolio with the addition of brands for both new build and the energy-efficient repair and refurbishment market.

These include prefabricated Ytong and Hebel autoclaved aerated concrete (AAC) modular systems, Silka calcium silicate elements, and, Multipor mineral insulation. The brands are underpinned by comprehensive digital service offering blue.sprint for linking 3D building models using AI and Building Information Modelling (BIM) directly to digitally managed factory production, ensuring smart-building processes and just-in-time onsite delivery.

Headquartered in Duisburg, Germany, the company has more than 4 000 employees, and is present in 22 European markets.

Miljan Gutovic, Holcim CEO: “This acquisition advances Holcim’s NextGen Growth 2030 strategy, accelerating our vision to be the leading partner for sustainable construction. By expanding our high-value building solutions portfolio with leading brands such as Ytong, Hebel, Silka and Multipor, the acquisition will enable Holcim to provide fully integrated sustainable and innovative walling systems to our customers. It enhances Holcim’s specification selling capabilities in modern sustainable construction, from circularity and energy-efficient refurbishment to smart design and modular building. I warmly welcome Xella’s more than 4 000 employees to the Holcim family.”

The transaction value represents a pro forma 2026 EBITDA multiple of 8.9x, or 6.9x after run-rate synergies of EUR 60 million realized in year three. It is expected to be earnings per share (EPS) and free cash flow accretive in year one and return on invested capital (ROIC) accretive in year three.

About Holcim
Holcim (SIX: HOLN) is the leading partner for sustainable construction with net sales of CHF 15.7 billion in 2025, creating value across the built environment from infrastructure and industry to buildings. Headquartered in Zug, Switzerland, Holcim has more than 45 000 employees in 43 attractive markets – across Europe, Latin America and Asia, Middle East & Africa – and has been recognized as a Global Top Employer by the Top Employers Institute. Holcim offers high-value end-to-end Building Materials and Building Solutions, from foundations and flooring to walling and roofing – powered by premium brands including ECOPact, ECOPlanet and ECOCycle.

Learn more about Holcim on www.holcim.com, and by following us on LinkedIn.

Sign up for Holcim's Building Progress newsletter here.

Important disclaimer – forward-looking statements:
This document contains forward-looking statements. Such forward-looking statements do not constitute forecasts regarding results or any other performance indicator, but rather trends or targets, as the case may be, including with respect to plans, initiatives, events, products, solutions and services, their development and potential. Although Holcim believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions as at the time of publishing this document, investors are cautioned that these statements are not guarantees of future performance. Actual results may differ materially from the forward-looking statements as a result of a number of risks and uncertainties, many of which are difficult to predict and generally beyond the control of Holcim, including but not limited to the risks described in  Holcim's annual report available on its website (
www.holcim.com) and uncertainties related to the market conditions and the implementation of our plans. Accordingly, we caution you against relying on forward-looking statements. Holcim does not undertake to provide updates of these forward-looking statements.



End of Media Release
View original content: EQS News


2349424  19.06.2026 CET/CEST

Passende Hebelprodukte

UBS Logo
Typ Hebel Verfall Valor
Long 7.45 18.12.2026 154259390
Long 11.92 15.12.2028 151874693
Long 715.2 18.09.2026 151031428
Typ Hebel Verfall Valor
Short 7.298 17.12.2027 156034532
Short 10.5176 18.12.2026 158463448
Short 715.2 21.08.2026 158569359
Typ Hebel Abstand Stop Loss Valor
Long 7.4417 11.04 154809780
Long 11.7246 5.80 158568854
Long 32.5091 0.26 157230902
Typ Hebel Abstand Stop Loss Valor
Short 6.9437 11.43 152989618
Short 8.3163 9.20 158464433
Short 12.7714 5.09 157689167
Typ Faktor Abstand zum Basispreis Valor
Long 5 -39.31 146215905
Long 8 -11.08 147182342
Long 12 -6.84 146536704
Typ Faktor Abstand zum Basispreis Valor
In eigener Sache

Trading Signals: BB Biotech: Comeback nimmt Fahrt auf

Der heimische Biotech-Investor überzeugt nicht nur mit starken Quartalszahlen: Auch schlägt das Portfolio den Branchenindex deutlich, während die Aktie dem inneren Wert noch hinterherhinkt. Genau darin liegt weiteres Kurspotenzial.

Weiterlesen!

Analysen zu Holcim AG

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
11.05.26 Holcim Overweight JP Morgan Chase & Co.
13.04.26 Holcim Buy Deutsche Bank AG
10.04.26 Holcim Buy Goldman Sachs Group Inc.
15.01.26 Holcim Outperform Bernstein Research
07.11.25 Holcim Outperform Bernstein Research
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio

Im BX Morningcall werden folgende Aktien analysiert und erklärt
✅ Wabtec
✅ Eli Lilly
✅ Novartis

https://bxplus.ch/bx-musterportfolio/

Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 15’196.05 19.62 S4B3QU
Short 15’506.89 13.70 SIBJOU
Short 16’092.22 8.85 S5B0BU
SMI-Kurs: 14’552.30 07.08.2026 17:30:00
Long 14’005.37 19.62 SYBQ3U
Long 13’702.27 13.96 SPB50U
Long 13’088.65 8.85 SVB5UU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

Holcim AG 70.78 -2.48% Holcim AG